Maynard Um
-
-
-
-
-
-
-
AN2 Therapeutics, Inc. (ANTX) Misses Q1 EPS by 10c
-
-
-
-
-
-
-
AN2 Therapeutics, Inc (ANTX) Provides Strategic Update for Phase 3 EBO-301 Trial
-
-
-
-
-
-
-
AN2 Therapeutics, Inc. (ANTX) Tops Q2 EPS by 13c
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

